We are live on
!
Find out more
EAM
Eventide Asset Management Portfolio holdings
AUM
$6.05B
1-Year Est. Return
76.64%
This Fund
S&P 500
This Quarter
Est. Return
+16.39%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.4B
AUM Growth
+$319M
(+5.3%)
Cap. Flow
-$191M
Cap. Flow
% of AUM
-2.99%
Top 10 Holdings %
Top 10 Hldgs %
23.07%
Holding
290
New
50
Increased
129
Reduced
80
Closed
21
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
+$43.3M |
| 2 |
Liberty Energy
LBRT
|
+$32.9M |
| 3 |
DexCom
DXCM
|
+$30.7M |
| 4 |
Apogee Therapeutics
APGE
|
+$27.5M |
| 5 |
Monolithic Power Systems
MPWR
|
+$26.1M |
Top Sells
| 1 |
Insmed
INSM
|
+$95.2M |
| 2 |
VRNA
Verona Pharma
VRNA
|
+$72.7M |
| 3 |
Guardant Health
GH
|
+$72.5M |
| 4 |
Celcuity
CELC
|
+$63.7M |
| 5 |
Evolent Health
EVH
|
+$53.2M |
Sector Composition
| 1 | Healthcare | 42.37% |
| 2 | Industrials | 17.69% |
| 3 | Technology | 15.85% |
| 4 | Consumer Discretionary | 6.94% |
| 5 | Utilities | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Flex
FLEX
$48.5B
| $13.4M | 0.21% |
220,510
-132,114
| -37% | -$8.16M |
|
127
Immix Biopharma
IMMX
$760M
| $13.3M | 0.21% |
+2,549,019
| New | +$10.5M |
|
128
Dyne Therapeutics
DYN
$3.93B
| $13.3M | 0.21% |
+680,305
| New | +$12.9M |
|
129
CG Oncology
CGON
$6.33B
| $13M | 0.2% |
+312,445
| New | +$12.9M |
|
130
Generac Holdings
GNRC
$13.3B
| $12.8M | 0.2% |
+93,860
| New | +$15.1M |
|
131
Intuit
INTU
$77.3B
| $12.4M | 0.19% |
18,720
+618
| +3% | +$408K |
|
132
Bloom Energy
BE
$69.2B
| $11.9M | 0.19% |
+137,263
| New | +$14.4M |
|
133
uniQure
QURE
$2.85B
| $11.9M | 0.19% |
+498,212
| New | +$19.2M |
|
134
ADC Therapeutics
ADCT
$156M
| $11.9M | 0.19% |
+3,364,067
| New | +$13.7M |
|
135
Castle Biosciences
CSTL
$701M
| $11.9M | 0.19% |
+305,000
| New | +$9.83M |
|
136
Home Depot
HD
$337B
| $11.7M | 0.18% |
33,865
+579
| +2% | +$212K |
|
137
TSMC
TSM
$2.18T
| $11.6M | 0.18% |
38,422
+22,219
| +137% | +$6.52M |
|
138
Medtronic
MDT
$102B
| $10.8M | 0.17% |
112,264
+58,023
| +107% | +$5.64M |
|
139
Verisk Analytics
VRSK
$25B
| $10.7M | 0.17% |
48,002
-134,008
| -74% | -$30.2M |
|
|
PVLA
140
Palvella Therapeutics
PVLA
$2.15B
| $10.6M | 0.17% |
+101,748
| New | +$8.68M |
|
141
CrowdStrike
CRWD
$215B
| $10.5M | 0.16% |
89,768
+1,816
| +2% | +$231K |
|
142
ServiceNow
NOW
$108B
| $10.4M | 0.16% |
68,035
+17,350
| +34% | +$2.98M |
|
|
HELP
143
Cybin Inc
HELP
$414M
| $10.3M | 0.16% |
+1,257,000
| New | +$8.09M |
|
144
Public Service Enterprise Group
PEG
$40.1B
| $10.2M | 0.16% |
127,174
-72,023
| -36% | -$5.88M |
|
145
IDEAYA Biosciences
IDYA
$3.53B
| $9.82M | 0.15% |
284,069
-341,635
| -55% | -$10.9M |
|
146
Southern Company
SO
$108B
| $9.69M | 0.15% |
110,842
-295,557
| -73% | -$27M |
|
147
Amgen
AMGN
$192B
| $9.32M | 0.15% |
28,372
+4,146
| +17% | +$1.32M |
|
148
Linde
LIN
$242B
| $9.08M | 0.14% |
21,278
-2,092
| -9% | -$896K |
|
149
enGene Therapeutics
ENGN
$127M
| $8.58M | 0.13% |
+950,000
| New | +$7.61M |
|
150
Wave Life Sciences
WVE
$1.18B
| $8.5M | 0.13% |
+500,000
| New | +$5.08M |
|
Similar funds
AWA
HPG
CDDEC
EMPI
RCG
WHRC
GA
JWBC